Acute and Subacute Toxicity Study of Water-Soluble Polyalkylsulfonated C 60 in Rats

Abstract

Polyalkylsulfonated C₆₀, or FC₄S, a highly water-soluble caged fullerene derivative, is believed to be a free radical remover or an antioxidant in biological systems. A 50 mg/ml aqueous solution was prepared as a master solution and administered to female Sprague-Dawley CD(Crl:CDR (SD)BR) rats in a single-dose acute toxicity study or a 12-day subacute toxicity study where rats were given the solution daily. In a study of the median lethal dose (LD₅₀), no rats died after oral administration, and thus FC₄S was considered to nontoxic if administered orally. In an LD₅₀ intraperitoneal injection study, rats died within 30 hr after injection; the LD₅₀ was determined to be approximately 600 mg per kilogram of body weight. Rats injected with the compound intraperitoneally or intravenously immediately eliminated the compound through the kidney; the kidney appeared to be the primary target organ. The compound induced a distinct lysosome-overload nephrosis, a phagolysosomal nephropathy characterized by a tinctorial difference between the outer cortex and the inner cortex and the medulla. The affected outer cortex showed a diffuse degeneration, with the presence of numerous large vacuoles and cytoplasmic aggregates in the tubular epithelium. The phagolysosomal nephropathy was detected in rats after acute exposure as well as in the surviving rats following 1 intraperitoneal injection of 500 mg/kg or intravenous injection of 100 mg/kg. Ultrastructural investigation revealed numerous membranous conglomerates characteristic of phagolysosomal and/or lysosomal inclusions in the cytoplasm of the renal tubular epithelium. These conglomerates were confined to the vacuole, electron-dense, and unevenly stained. They varied in size and shape and were fused or aggregated. Occasional phagolysosomes were also observed in the endothelial cells of the peritubular plexus. A preliminary study of microsomal enzyme activity analysis revealed a suppression effect of liver cytochrome P-450–dependent monooxygenase activities, including cytochrome P-450, cytochrome b₅, and benzo(a)pyrene hydroxylase, but an increased level of kidney cytochrome P-450–dependent monooxygenase activities, including NADPH-cytochrome P-450 reductase. The significance of these enzyme alterations was not well determined. Further study is needed to clarify the correlation between the alterations of microsomal enzyme activity and the nephropathy of lysosomal overload-induced changes. These changes may serve as a biological marker in toxicity screening tests for this class of compound.

Keywords

Acute toxicity FC4S (polyalkylsulfonated C60)free radical remover fullerene phagolysosomal nephropathy rats water-soluble C60 derivative

References

1. Alden CL and Frith CH (1991). Urinary system. In: Handbook of Toxicologic Pathology, Haschek VM and Rousseaux CG (eds). Academic Press, New York, pp. 315–387.

2. Alvares AP and Mannering GJ (1970). Two substrate kinetics of drug-metabolizing enzyme system of hepatic microsomes. Mol. Pharmacol. 6: 202–212.

3. Battenfeld R , Rahman Khater AE , Drommer W , Guenzel P , and Kaup FJ (1991). Ioxoglate induced light and electron microscope alterations in the renal proximal tubular epithelium of rats. Invest. Radiol. 26: 35–39.

4. Borghoff SJ , Short BG , and Swenberg JA (1990). Biochemical mechanism and pathobiology of a2u-globulin nephropathy. Annu. Rev. Pharmacol. Toxicol. 30: 349–367.

5. Bulger RE (1986). Kidney morphology: Updated 1985. Toxicol. Pathol. 14: 13–25.

6. Chen HHC , Yu C , Ueng TH , Liang CT , Chen BJ , Hong CC , and Chiang LY (1997). Renal toxic effects of water soluble polyalkyl-sulfonated C60 with an acute study in rats. 12th General Symposium on Fullerenes, Fullerenes Research Association, January 13–14, 1997, 28–29, in Tokyo, Japan (in Japanese or English).

7. Chen HHC , Yu C , Ueng TH , Liang CT , Chen BJ , Hong CC , and Chiang LY (1997). Renal toxic effects of water soluble polyalkyl-sulfonated C60 with an acute study in rats. Fullerene Sci. Technol. 5: 1387–1395.

8. Chen SC , Lai MK , Hsieh CH , Chueh SC , Chiang LY , and Chen WC (1997). The effects of fullerenols on the preservation of canine renal grafts–-preliminary reports. 12th General Symposium on Fullerenes, Fullerenes Research Association, January 13–14, 1997, 31, in Tokyo, Japan (in Japanese or English).

9. Chiang LY , Lu FJ , and Lin JT (1995). Free radical scavenging activity of water soluble fullerenols. J. Chem. Soc. Chem. Commun. 1283–1284.

10.

10. Chiang LY , Lu FJ , and Lin JT (1995). Free radical scavenging activity of water soluble [60] fullerenols in whole blood associated with gastric cancer. Proc. Electrochemical Soc. 95: 699–705.

11.

11. Chiang LY , Swirczewski JW , Hsu CS , Chowdhury SK , Cameron S , and Creegan K (1992). Multi-hydroxy additions onto C60, fullerene molecules”. J. Chem. Soc. Chem. Commun. 1791–1793.

12.

12. Chiang LY , Upasani RB , and Swirczewski JW (1992). Versatile nitroniumchemistry for C60 fullerene functionalization. J. Am. Chem. Soc. 114: 10154–10157.

13.

13. Christensen EI and Maunsbach AB (1979). Effects of dextran on lysosomal ultrastructure and protein digestion in renal proximal tubule. Kidney Int. 16: 301–311.

14.

14. Diederich F and Thilgen C (1996). Covalent fullerene chemistry. Science 271: 317–323.

15.

15. Greenlee WF and Poland A (1978). An improved assay of 7-ethoxycoumarin O-deethylase activity: Induction of hepatic enzyme activity in C57BL/6J and DBA/2J mice by phenobarbital, 3-methyl-cholanthrene and 2,3,7,8-tetrachlorodibenzo-p-dixoixin. J. Pharmacol. Exp. Ther. 205: 596–605.

16.

16. Guengerich FP (1992). Metabolic activation of carcinogens. Pharmacol. Ther. 54: 17–61.

17.

17. Halpert JR (1995). Structural basis of selective cytochrome P450 inhibition. Ann. Rev. Pharmacol. Toxicol. 35: 29–53.

18.

18. Hsu HC , Lee YT , Chiang LY , and Chen WC (1997). Effects of water-soluble fullerene derivatives on lipoprotein oxidation. 12th General Symposium on Fullerenes, Fullerenes Research Association, January 13–14, 1997, 33, in Tokyo, Japan (in Japanese or English).

19.

19. Huang HC , Lu LH , and Chiang LY (1996). Antiproliferative effect of polyhydroxylated C60 on vascular smooth muscle cells. Proc. Electrochemical Soc. 96: 403–406.

20.

20. Huang HC , Lu LH , and Chiang LY (1997). Possible mechanisms of antiproliferative effect of fullerenol on vascular smooth muscle cells, as compared with activities of vitamin C and E. 12th General Symposium on Fullerenes, Fullerenes Research Association, January 13–14, 1997, 32, in Tokyo, Japan (in Japanese or English).

21.

21. Imai Y , Ito A , and Sato R (1966). Evidence for biochemically different types of vesicles in the hepatic microsomal fraction. J. Biochem. (Tokyo) 60: 417–428.

22.

22. Kosek JC , Mazze RI , and Cousins MJ (1974). Nephrotoxicity of gentamicin. Lab. Invest. 30: 48–57.

23.

23. Krusic PJ , Wasserman E , Keiger PN , Morton JR , and Preston KF (1991). Radical reaction of C60. Science 254: 1183–1185.

24.

24. Longnecker DS , Skinozuka H , and Farber E (1968). Molecular pathology of in vivo inhibition of protein synthesis. Am. J. Pathol. 52: 891–915.

25.

25. Lowry OH , Rosebrough NJ , Farr AL , and Randall RJ (1951). Protein determinations with Folin phenol reagent. J. Biol. Chem. 193: 265–275.

26.

26. Maunsbach AB , Madden SC , and Latta H (1962). Light and electron microscopic changes in proximal tubules of rats after administration of glucose, mannitol, sucrose, or dextran. Lab. Invest. 11: 421–432.

27.

27. Nash T (1953). The colorimetric estimation of formaldehyde by means of the Hantzoch reaction. Biochem. J. 55: 416–421.

28.

28. Nebert DV and Gelboin HV (1968). Substrate-inducible microsomal aryl hydroxylase in mammalian cell culture. I. Assay and properties of induced enzyme. J. Biol. Chem. 243: 2642–2649.

29.

29. Omura T and Sato R (1964). The carbon monoxide-binding pigment of liver microcosms. I. Evidence for its hemoprotein nature. J. Biol. Chem. 239: 2370–2378.

30.

30. Phillips AH and Lang don RG (1962). Hepatic triphosphopyridine nucleotide-cytochrome reductase: Isolation, characterization, and kinetic studies. J. Biol. Chem. 237: 2652–2660.

31.

31. Ryan DE and Levin V (1990). Purification and characterization of hepatic microsomal cytochrome P450. Pharm. Ther. 45: 153–239.

32.

32. Sijbesma R , Srdanov G , Wudl F , Castoro JA , Wilkins C , Friedman SH , DeCamp DL , and Kenyon GL (1993). Synthesis of a fullerene derivative for the inhibition of HIV enzymes. J. Am. Chem. Soc. 115: 6510–6512.

33.

33. Tervahartiala P , Kivisaari L , Kivisaari R , Virtanen I , and Standertskjold-Nordenstam CG (1991). Contrast media-induced renal tubular vacuolization a light and electron microscopic study on rat kidneys. Invest. Radiol. 26: 882–887.

34.

34. Tsai MC , Chen YH , and Chiang LY (1997). Polyhydroxylated C60, fullerenol, a novel free-radical trapper, prevented hydrogen peroxide-and cumene hydroperoxide-elicited changes in rat hippocampus in-vitro. J. Pharm. Pharmacol. 49: 438–445.

35.

35. Tylor R and Walton DRM (1993). The chemistry of fullerenes. Nature 363: 685–693.

36.

36. Ueng TH , Kang JJ , Wang HW , Cheng YW , and Chiang LY (1997). Suppression of microsomal cytochrome P450-dependent monooxygenases and mitochondrial oxidative phosphorylation by fullerenol, a polyhydroxylated fullerene C60. Toxicol. Lett. 93: 29–37.